STAT News

STAT+: Skylark Bio kicks off new gene therapy trial for deafness

Biotech startups in the U.S., France, and China are racing to bring new gene therapies for deafness by targeting different genetic mutations.

Por STAT News

1 minuto de lectura
Compartir
STAT+: Skylark Bio kicks off new gene therapy trial for deafness
STAT+: Skylark Bio kicks off new gene therapy trial for deafness

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas